MediBeacon came to Speck with their first product platform, a transdermal GFR monitor. The innovative system offers real-time, easy to use, and cost-effective monitoring of kidney function. MediBeacon’s noninvasive monitoring technology allows for earlier detection of renal issues enabling clinicians to provide earlier, and hence more effective interventions. The technology needed to be low cost and straightforward to integrate into existing ICU rooms and workflows. In order to design a clear and appropriate interface, it was also crucial to understand how intensive care nurses would place the sensor on patients, administer the reagent, and interact with critical care patients.